Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$10.9564 -1.29%
Market Cap
$210.5M
Price Target
Refer to Report
Volume
9.7K
52wk Range
$7.65 - $32
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).